{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T15:48:27Z","timestamp":1721404107434},"reference-count":56,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,13]]},"DOI":"10.18632\/oncotarget.24833","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T13:50:43Z","timestamp":1523627443000},"page":"19767-19782","source":"Crossref","is-referenced-by-count":4,"title":["Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions"],"prefix":"10.18632","volume":"9","author":[{"given":"Anne M.-Y.","family":"Hsieh","sequence":"first","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Polyakova","sequence":"additional","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Fu","sequence":"additional","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Chazen","sequence":"additional","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"MacMillan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J.","family":"Witterick","sequence":"additional","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"},{"name":"Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Otolaryngology-Head and Neck Surgery, Sinai Health System, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranju","family":"Ralhan","sequence":"additional","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"},{"name":"Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Otolaryngology-Head and Neck Surgery, Sinai Health System, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Walfish","sequence":"additional","affiliation":[{"name":"Alex and Simona Shnaider Research Laboratory in Molecular Oncology, Sinai Health System, Toronto, ON, Canada"},{"name":"Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Otolaryngology-Head and Neck Surgery, Sinai Health System, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12022-010-9141-8","article-title":"Encapsulated malignant follicular cell-derived thyroid tumors","volume":"21","author":"Ghossein","year":"2010","journal-title":"Endocr Pathol"},{"key":"2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.humpath.2015.01.010","article-title":"Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant","volume":"46","author":"Ghossein","year":"2015","journal-title":"Hum Pathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/CCO.0000000000000341","article-title":"The follicular variant of papillary thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"29","author":"Randolph","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Khanafshar","year":"2016","journal-title":"JAMA Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1089\/thy.2015.0114","article-title":"Immunohistochemical subcellular localization of protein biomarkers distinguishes benign from malignant thyroid nodules: potential for fine-needle aspiration biopsy clinical application","volume":"25","author":"Walfish","year":"2015","journal-title":"Thyroid"},{"key":"6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/pmic.201200356","article-title":"Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas","volume":"13","author":"Walfish","year":"2013","journal-title":"Proteomics"},{"key":"7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/1471-2407-12-523","article-title":"Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma","volume":"12","author":"Walfish","year":"2012","journal-title":"BMC Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/thy.2012.0405","article-title":"Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival","volume":"23","author":"Walfish","year":"2013","journal-title":"Thyroid"},{"key":"9","doi-asserted-by":"publisher","first-page":"e42893","DOI":"10.1371\/journal.pone.0042893","article-title":"An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma","volume":"7","author":"Walfish","year":"2012","journal-title":"PLoS One"},{"key":"10","doi-asserted-by":"publisher","first-page":"e40956","DOI":"10.1371\/journal.pone.0040956","article-title":"Biotinidase is a novel marker for papillary thyroid cancer aggressiveness","volume":"7","author":"Walfish","year":"2012","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"publisher","first-page":"32318","DOI":"10.18632\/oncotarget.8698","article-title":"Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants","volume":"7","author":"Walfish","year":"2016","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/thy.2016.0228","article-title":"Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathologic factors and recurrence","volume":"27","author":"Ji","year":"2017","journal-title":"Thyroid"},{"key":"13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ebiom.2017.03.031","article-title":"Programmed Death-Ligand 1 expression distinguishes invasive encapsualted follicular variant of papillary thyroid carcinoma from noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"18","author":"Walfish","year":"2017","journal-title":"EBioMedicine"},{"key":"14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ebiom.2017.03.035","article-title":"New Insight in a new entity: NIFTPS and valuable role of ancillary techniques. The role of PD-L1","volume":"18","author":"Martini","year":"2017","journal-title":"EBioMedicine"},{"key":"15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12022-017-9478-3","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: historical context, diagnosis, and future challenges","volume":"28","author":"Ghossein","year":"2017","journal-title":"Endocr Pathol"},{"key":"16","first-page":"537","article-title":"Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis","volume":"13","author":"Katsilambros","year":"2008","journal-title":"J BUON"},{"key":"17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13000-015-0262-8","article-title":"Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential","volume":"10","author":"Marbaix","year":"2015","journal-title":"Diagn Pathol"},{"key":"18","doi-asserted-by":"publisher","first-page":"e0148656","DOI":"10.1371\/journal.pone.0148656","article-title":"An appraisal of proliferation and apoptotic markers in papillary thyroid carcinoma: an automated analysis","volume":"11","author":"Marbaix","year":"2016","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/jclinpath-2016-204107","article-title":"Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms","volume":"70","author":"Tamimi","year":"2017","journal-title":"J Clin Pathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13058-016-0682-8","article-title":"Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"18","author":"Houston","year":"2016","journal-title":"Breast Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00428-016-1907-z","article-title":"Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma","volume":"468","author":"Ellis","year":"2016","journal-title":"Virchows Arch"},{"key":"22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1097-0142(19980425)84:2<115::AID-CNCR8>3.0.CO;2-O","article-title":"Morphometry in the cytologic evaluation of thyroid follicular lesions","volume":"84","author":"Nakajima","year":"1998","journal-title":"Cancer"},{"key":"23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2559.1999.00641.x","article-title":"The value of histomorphometric nuclear parameters in the diagnosis of well differentiated follicular carcinomas and follicular adenomas of the thyroid gland","volume":"34","author":"Boss","year":"1999","journal-title":"Histopathology"},{"key":"24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF03032605","article-title":"Evaluation of diagnostic efficiency of computerized image analysis based quantitative nuclear parameters in papillary and follicular thyroid tumors using paraffin-embedded tissue sections","volume":"7","author":"Karak","year":"2001","journal-title":"Pathol Oncol Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1440-1827.2005.01895.x","article-title":"Computerized nuclear morphometry in thyroid follicular neoplasms","volume":"55","author":"Chai","year":"2005","journal-title":"Pathol Int"},{"key":"26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3332\/ecancer.2009.146","article-title":"Computerized nuclear morphometry in the diagnosis of thyroid lesions with predominant follicular pattern","volume":"3","author":"Zahran","year":"2009","journal-title":"Ecancermedicalscience"},{"key":"27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.patrec.2014.02.008","article-title":"Cancer diagnosis by nuclear morphometry using spatial information","volume":"42","author":"Rohde","year":"2014","journal-title":"Pattern Recognit Lett"},{"key":"28","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C","article-title":"Correlation of nuclear morphometry with progression of breast cancer","volume":"68","author":"Coffey","year":"1991","journal-title":"Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s004050050153","article-title":"The use of nuclear morphometry for the prediction of survival in patients with advanced cancer of the larynx","volume":"256","author":"Olszewski","year":"1999","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/aja.2011.148","article-title":"Nuclear morphometry, nucleomics and prostate cancer progression","volume":"14","author":"Isharwal","year":"2012","journal-title":"Asian J Androl"},{"key":"31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1348-8643(09)80003-7","article-title":"Morphometric analysis of nuclear features and volume-corrected mitotic index in the prognosis of oral squamous cell carcinoma","volume":"6","author":"George","year":"2009","journal-title":"Oral Sci Int"},{"key":"32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5958\/2394-6792.2015.00031.9","article-title":"Role of computer assisted nuclear morphometric analysis in grading of infiltrating ductal carcinoma of breast (Nos type) and correlation with established prognostic markers","volume":"2","author":"Prakashini Manjunath","year":"2015","journal-title":"Indian Journal of Pathology and Oncology"},{"key":"33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.celrep.2014.01.035","article-title":"Tumor evolution in response to chemotherapy: phenotype versus genotype","volume":"6","author":"Navin","year":"2014","journal-title":"Cell Reports"},{"key":"34","first-page":"525","article-title":"Histopathologic pattern of thyroid disease","volume":"80","author":"Ergete","year":"2003","journal-title":"East Afr Med J"},{"key":"35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.14310\/horm.2002.11118","article-title":"Histopathology of thyroid tumors. An overview","volume":"3","author":"Scopa","year":"2004","journal-title":"Hormones (Athens)"},{"issue":"Suppl 2","key":"36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/modpathol.2010.129","article-title":"Papillary thyroid carcinoma: an update","volume":"24","author":"LiVolsi","year":"2011","journal-title":"Mod Pathol"},{"key":"37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/labinvest.2012.91","article-title":"Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue","volume":"92","author":"Lange","year":"2012","journal-title":"Lab Invest"},{"key":"38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1043\/1543-2165-133.5.683","article-title":"Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin","volume":"133","author":"Ghossein","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/modpathol.2017.9","article-title":"Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"30","author":"Jung","year":"2017","journal-title":"Mod Pathol"},{"key":"40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00268-017-4182-5","article-title":"Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign?","volume":"42","author":"Pasternak","year":"2018","journal-title":"World J Surg"},{"key":"41","doi-asserted-by":"publisher","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Chen","year":"2012","journal-title":"Sci Transl Med"},{"key":"42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/ERC-12-0313","article-title":"Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation","volume":"20","author":"Ward","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.humpath.2015.05.016","article-title":"The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer","volume":"46","author":"Kreipe","year":"2015","journal-title":"Hum Pathol"},{"key":"44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.21079","article-title":"Risk factors for thyroid cancer: a prospective cohort study","volume":"116","author":"Rohan","year":"2005","journal-title":"Int J Cancer"},{"key":"45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12967-014-0369-9","article-title":"Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients","volume":"13","author":"Sharma","year":"2015","journal-title":"J Transl Med"},{"key":"46","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.5858\/arpa.2014-0074-RA","article-title":"Standardization of diagnostic immunohistochemistry: literature review and geisinger experience","volume":"138","author":"Chen","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.5858\/arpa.2013-0610-CP","article-title":"Principles of analytic validation of immunohistochemical assays: guideline from the College of American Pathologists Pathology and Laboratory Quality Center","volume":"138","author":"Swanson","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/PAP.0000000000000094","article-title":"Principles of analytic validation of clinical immunohistochemistry assays","volume":"22","author":"Swanson","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2478\/v10042-008-0114-4","article-title":"Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice","volume":"47","author":"Slodkowska","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"50","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/0192623311419163","article-title":"The use of immunohistochemistry for biomarker assessment\u2014can it compete with other technologies?","volume":"39","author":"Lowe","year":"2011","journal-title":"Toxicol Pathol"},{"issue":"Suppl 1","key":"51","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1746-1596-9-S1-S10","article-title":"Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system","volume":"9","author":"Laurinavicius","year":"2014","journal-title":"Diagn Pathol"},{"key":"52","unstructured":"NIFTP. Mutations in Various Thyroid Tumours. http:\/\/niftp.org\/Mutations_in_Various_Thyroid_Tumours.html."},{"key":"53","first-page":"1130","article-title":"Follicular thryoid carcinoma with capsular invasion alone: a nonthreatening malignancy","volume":"112","author":"Grant","year":"1992","journal-title":"Surgery"},{"key":"54","first-page":"152","volume-title":"Diagnostic pathology and molecular genetics of the Thyroid: a comprehensive guide for practicing thyroid pathology","author":"Thomapson","year":"2012","edition":"2"},{"key":"55","volume-title":"Protocol for the Examination of Specimens from patients with carcinomas of the thyroid gland","author":"Thompson","year":"2017"},{"key":"56","volume-title":"Robbins and Cotran Pathologic Basis of Disease","author":"Aster","year":"2015","edition":"9"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:29:04Z","timestamp":1589041744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":56,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2018,4,13]]}},"alternative-id":["24833","29731981"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24833","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]}}}